A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?
about
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor AgonistsRole of nitric oxide synthases in the infarct size-reducing effect conferred by heat stress in isolated rat heartsPre-infarction angina and outcomes in non-ST-segment elevation myocardial infarction: data from the RICO survey.New insights into cardioprotection by ischemic preconditioning and other forms of stress.Pharmacologic enhancement of tolerance to ischemic cardiac stress using monophosphoryl lipid A. A comparison with antecedent ischemia.Pathophysiology of ischaemia-reperfusion injury.Molecular mechanisms mediating preconditioning following chronic ischemia differ from those in classical second window.Association between clinical presentations before myocardial infarction and coronary mortality: a prospective population-based study using linked electronic records.Neutrophil-endothelial cell interactions during the development of tolerance to ischaemia/reperfusion in isolated cells.Clinical relevance of ischemic preconditioning.Preconditioning - endogenous defence mechanisms of the heart.Understanding myocardial ischemic preconditioning, and the implications for a role of adenosine catabolism.Mechanisms underlying acute protection from cardiac ischemia-reperfusion injuryIschaemic preconditioning: therapeutic implications for stroke?Level of Physical Activity and In-Hospital Course of Patients with Acute Coronary SyndromeCoronary vasoregulation in health and diseaseIschemic preconditioning: protection against myocardial necrosis and apoptosis.Nitrite as a mediator of ischemic preconditioning and cytoprotection.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Cardioprotection acquired through exercise: the role of ischemic preconditioning.Recovery of hibernating myocardium: what is the role of surgical revascularization?Cardiac Remote Ischemic Preconditioning Prior to Elective Vascular Surgery (CRIPES): A Prospective, Randomized, Sham-Controlled Phase II Clinical Trial.Clinical characteristics and outcome of patients with acute myocardial infarction and preinfarction angina.Protection by preconditioning and cardiac pacing against ventricular arrhythmias resulting from ischemia and reperfusion.Myocardial adaptation, stress proteins, and the second window of protection.Ischaemic preconditioning of myocardium.Time Frame of Ischemic Preconditioning: Is It Clinically Relevant?Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.Argon Induces Protective Effects in Cardiomyocytes during the Second Window of Preconditioning.The role of hypoxia-inducible factor-1α and vascular endothelial growth factor in late-phase preconditioning with xenon, isoflurane and levosimendan in rat cardiomyocytes.Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium.Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin.Expression of HSPs: an adaptive mechanism during long-term heat stress in goats (Capra hircus).Plasma nitric oxide metabolite levels increase during successive exercise stress testing - A link to delayed ischemic preconditioning?Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.Enhanced iNOS function in myocytes one day after brief ischemic episode.Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes.Coronary blood flow in evolving myocardial infarction preceded by preinfarction angina: a critical reevaluation of preconditioning effects in clinical cases.Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart.Use of suppression subtractive hybridization strategy for discovery of increased tissue inhibitor of matrix metalloproteinase-1 gene expression in brain ischemic tolerance.
P2860
Q28066192-B18091DB-F9CE-40EE-90CC-5B280C9C6AEBQ28363089-AFD8E84B-5BEA-495D-9391-0C762FAA6E3BQ30583477-B2C8333E-5AFC-4CF9-AC99-E9760AAECE23Q33692425-EBA96281-08E2-4377-AE3E-E34C83BF798AQ33692437-83C1D003-7343-4BB9-9EAD-F5CAC64161C5Q33843544-E1E43861-40AA-4524-9AD1-3AE5B1F13FC5Q34150639-291815DF-3435-4DDE-A612-C62EE845133FQ34175999-DF0561C1-6A14-4C32-8765-F61140DD5FC7Q34418954-AF5B3D32-30BE-4DB5-9C70-391DC0B04457Q34523796-9F3D31F9-65E4-458D-80A0-8FE5FE5C4B43Q34593774-284E204C-6821-4134-BE8B-037F518D5EACQ35072009-978812F3-3B46-4F2A-8AA6-9D917D0605F0Q35424798-42902328-DAA6-479A-92CF-C1E9651679A0Q35753366-7FD4C643-F8F8-410E-B810-126CDAFFD8B4Q36507321-F1763751-1FC4-4E54-A14F-C43DE4453A14Q36969052-365D4C56-9102-46AE-99ED-860CF389D750Q37031353-4A5BEF72-1A3A-477F-B169-D7904F87CC70Q37833367-3AE72B61-A75B-46D3-852C-CF68680958AAQ38191658-5DA69A8D-C7AD-4D7B-AAA2-97F1A57CC8C3Q38203574-ABDA3C2A-DE4A-434D-9645-C51F36E40ED4Q38282362-147E8A98-90D3-4A36-8771-082A481712EBQ38385560-23D82140-EA74-4E74-86A1-7FAFB225FA21Q41112581-C1318391-C78B-4641-8887-C237BE036BDFQ41200559-4BEF55DC-03BD-4B3C-975E-E7A81F3B50D6Q41200575-178C78DB-F4C2-48A7-8ACE-35E4F7DC2FC0Q41647765-88EA98F9-42B0-47B0-B05B-1A4A67D3262FQ41720804-40C4FD7B-BECD-4A76-95FE-80885DCD6D58Q41826761-724D0A16-C15D-45C6-87BB-CD527BBEE22FQ41826860-86D71BB7-0CAA-4495-8181-7B09493D621CQ41968134-CA335680-3676-4913-B159-A81D6908D15CQ41985628-B7A16DBE-F49A-4DF8-8197-45B2EE971BF1Q42057890-E2FEAA57-767A-4A87-AE29-AFBF7392CB04Q42467706-B1FBF9C9-E82A-4E83-BE7B-22727B3C214FQ42583663-BDA2A4FC-CA70-4307-814A-A1633E0759E6Q43737906-498D1B18-4107-4049-A335-B4A065E889CAQ43852645-5278120D-A1F2-4014-997D-F1CE62DFC241Q44185555-27E43116-3AEA-4A65-93AC-00B55B24D0D8Q44753298-B216E485-7557-4357-A063-0780D53670ECQ46592225-5D36C8D1-1B39-4C69-8D90-6662A4829138Q48354229-E8D4A587-6050-405F-8771-BF4C7459415F
P2860
A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection?
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
A "second window of protection ...... ons for myocardial protection?
@en
type
label
A "second window of protection ...... ons for myocardial protection?
@en
prefLabel
A "second window of protection ...... ons for myocardial protection?
@en
P1476
A "second window of protection ...... ons for myocardial protection?
@en
P2093
P304
P356
10.1016/0022-2828(95)90071-3
P577
1995-04-01T00:00:00Z